Business modelsB2B

Products 61 to 70 of 162

Dragon Silk by Kraig Biocraft Laboratories
Biotech components: Animal
Business models: B2B
Country of production: USA
Country of distribution: USA + Vietnam
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: 5,000,000 USD
Funding types: Government + Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Fiber
Production process: Closed Production
Source: Scientist Magazine
Trading symbol: KBLB (OTCMKTS)
Value chain stage: Input
Biotech components: Gene Editing + Plant
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:38 (2 years ago)
Date last modified: 2020/12/18 14:38 (2 years ago)
Known funding amount: N/A
Funding types: Private Funding + University
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Food
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Biotech components: Animal
Business models: B2B
Country of production: USA
Country of distribution: Brazil + USA + India + Panama + Cayman Islands
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: 26,132,305 GBP
Funding types: Private Funding
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Open Release
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Bacteria
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: N/A
Funding types: N/A
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Resource Extraction
Production process: Open Release
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
Epidiolex by EPIDIOLEX
Biotech components: N/A
Business models: B2B
Country of production: N/A
Country of distribution: USA
Intended consumer: Commercial + Consumer
Date added: 2019/04/01 10:02 (3 years ago)
Date last modified: 2019/04/12 09:32 (3 years ago)
Known funding amount: N/A
Funding types: N/A
Industry: Medical
Market status: On the market
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Eradicake Alpha-Amylase by BASF + Verenium
Biotech components: Enzyme
Business models: B2B
Country of production: Switzerland
Country of distribution: USA + Mexico + Canada + Germany + Singapore + Brazil + China
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/12/26 15:23 (4 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BAS (ETR)
Value chain stage: Input
EveNootkatone by Evolva
Biotech components: Plant
Business models: B2B
Country of production: Switzerland
Country of distribution: USA + Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: 86,000,000 CHF
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Public Company
Product categories: Additive
Production process: Closed Production
Source: SynBio Database
Trading symbol: EVE (SWX)
Value chain stage: Input
EverSweet™ by Evolva + Cargill
Biotech components: Plant
Business models: B2B + B2C
Country of production: Switzerland
Country of distribution: USA + Europe
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/09/13 15:54 (4 years ago)
Known funding amount: 86,000,000 CHF
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: NASEM Database
Trading symbol: EVE (SWX)
Value chain stage: Input
Farnesene by Amyris
Biotech components: Fungus
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: 471,900,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: AMRS (NASDAQ)
Value chain stage: Input
Biotech components: Animal
Business models: B2B
Country of production: UK
Country of distribution: England + USA
Intended consumer: Government
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: 36,300,000 USD
Funding types: Private Funding
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Other
Production process: Open Release
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product